Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†

Cited by (1,000)

Items 701–800 of 1,000

1. La Estoria de España de Alfonso X: creación y evolución
   Diego Catalán · 1992
2. Excess cholesterol and fat in the diet: A dangerous liaison for energy expenditure and the liver
   Brent A. Neuschwander‐Tetri, David Q.‐H. Wang · 2012 · Hepatology
3. Non-alcoholic fatty liver disease
   Pauline L. M. Verhaegh · 2021
4. Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease
   Laursen, Tea Lund, Mellemkjær, Anders, Møller, Holger Jon, Grønbæk, Henning, Kazankov, Konstantin · 2022 · Expert Opinion on Therapeutic Targets
5. Advancements in the understanding of mechanisms of the IL-6 family in relation to metabolic-associated fatty liver disease
   Jiale Liu, Tao Wang, Fuyuan Yang, Ciren Pubu · 2025 · Frontiers in Endocrinology
6. Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment
   Wensheng Che, Ming Zhao, Xiaoqing Li, Chunlong Li, William Chi Shing Cho, Shan Yu · 2022 · Frontiers in Endocrinology
7. Comparison of prepartum blood parameters in dairy cows with postpartum ketosis and new risk prediction candidates
   Woojae Choi, Younghye Ro, Eunhui Choe, Leegon Hong, Dohee Kim, Seongdae Kim, Ilsu Yoon, Danil Kim · 2023 · Frontiers in Veterinary Science
8. Microbial-Based Bioactive Compounds to Alleviate Inflammation in Obesity
   Oladayo Emmanuel Apalowo, Grace Adeola Adegoye, Tolulope Mobolaji Obuotor · 2024 · Current Issues in Molecular Biology
9. Mixed exposure to haloacetaldehyde disinfection by-products exacerbates lipid aggregation in the liver of mice
   Meiyue Qiu, Lili Yang, Zhiqiang Jiang, Yu Chen, Qinxin Liu, Xia Wang, Weidong Qu · 2024 · Environmental Pollution
10. Regulation of hepatic lipogenesis by asymmetric arginine methylation
    Hye-Sook Han, Byeong Hun Choi, Seo Young Jang, Seri Choi, Geum‐Sook Hwang, Seung‐Hoi Koo · 2024 · Metabolism
11. Nicotinamide Adenine Dinucleotide Phosphate Oxidases and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Vittoria Cammisotto, Emanuele Valeriani, Pasquale Pignatelli, Francesco Violi · 2025 · Antioxidants
12. Pharmacological therapy for non‐alcoholic steatohepatitis: How efficient are thiazolidinediones?
    Vlad Ratziu, Loredana Pienar · 2011 · Hepatology Research
13. Multi-Omics Integration to Reveal the Mechanism of Hepatotoxicity Induced by Dictamnine
    Can Tu, Ziying Xu, Lichun Tian, Zihui Yu, Tieshang Wang, Zhaojuan Guo, Jingxuan Zhang, Ting Wang · 2021 · Frontiers in Cell and Developmental Biology
14. Effects of Keemun and Dianhong Black Tea in Alleviating Excess Lipid Accumulation in the Liver of Obese Mice: A Comparative Study
    Wenjing Liao, Suyu Liu, Yunxi Chen, Ya-Shuai Kong, Dongxu Wang, Yijun Wang, Tie-Jun Ling, Zhongwen Xie, Irada S. Khalilova, Jinbao Huang · 2022 · Frontiers in Nutrition
15. Hepatic Mitochondrial Dysfunction and Risk of Liver Disease in an Ovine Model of “PCOS Males”
    Katarzyna J. Siemienowicz, Panagiotis Filis, Jennifer L. Thomas, Paul Fowler, William Colin Duncan, Mick T. Rae · 2022 · Biomedicines
16. Fluorescing fatty acids in rat fatty liver models
    Anna Cleta Croce, Andrea Ferrigno, Laura Giuseppina Di Pasqua, Clarissa Berardo, Barbara Mannucci, Giovanni F. Bottiroli, Mariapia Vairetti · 2016 · Journal of Biophotonics
17. Antihypercholesterolemic Effects of Fruit Aqueous Extract of Copernicia prunifera (Miller) H. E. Moore in Mice Diet‐Induced Hypercholesterolemia
    Raquel Teixeira Terceiro Paim, Stephen Rathinaraj Benjamin, Davide Rondina, Márcia Maria Mendes Marques, Daniel de Araújo Viana, Maria Leônia da Costa Gonzaga, Ícaro Gusmão Pinto Vieira, Francisca Noélia Pereira Mendes, Paula Alves Salmito Rodrigues, Maria Izabel Florindo Guedes · 2017 · Evidence-based Complementary and Alternative Medicine
18. Sexual dimorphism in hepatic lipids is associated with the evolution of metabolic status in mice
    Ana Francisca Soares, Jonathan Paz Montoya, Hongxia Lei, Marc Moniatte, Rolf Gruetter A · 2017 · NMR in Biomedicine
19. Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?
    Mikkel Breinholt Kjær, Jacob George, Konstantin Kazankov, Henning Grønbæk · 2020 · Expert Review of Gastroenterology & Hepatology
20. Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals
    In Young Cho, Yoosoo Chang, Eunju Sung, Jae‐Heon Kang, Ho Cheol Shin, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu · 2021 · Clinical Gastroenterology and Hepatology
21. THE IMPACT OF THE USE OF SYMBIOTICS IN THE PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE IN A RAT MODEL
    Eliane TAGLIARI, Antônio Carlos Ligocki Campos, Thaís Andrade Costa-Casagrande, Paolo R. O. Salvalaggio · 2017 · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
22. Proteomics for studying the effects of L. rhamnosus LV108 against non-alcoholic fatty liver disease in rats
    Hengxian Qu, Hongbo Yu, Ruixia Gu, Dawei Chen, Xia Chen, Ying‐Ping Huang, Wenbo Xi, Yujun Huang · 2018 · RSC Advances
23. New insights in the pathophysiology of chronic intermittent hypoxia-induced NASH: the role of gut–liver axis impairment
    Judith Aron‐Wisnewsky, Jean‐Louis Pépin · 2015 · Thorax
24. FGF21: A Sharp Weapon in the Process of Exercise to Improve NAFLD
    Zhiyuan Wang, Tingting Sun, Jingjing Yu, Siyu Li, Lijing Gong, Yimin Zhang · 2023 · Frontiers in Bioscience-Landmark
25. Chronic exposure to 3,6-dichlorocarbazole exacerbates non-alcoholic fatty liver disease in zebrafish by disrupting lipid metabolism and inducing special lipid biomarker accumulation
    Cunchuang Hou, Mengyao Huang, Pingping Wang, Qiaoyun Zhang, Guowei Wang, Shixiang Gao · 2024 · Chemosphere
26. The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies
    Hessam Yaghmaei, Amirhossein Bahanesteh, Masood Soltanipur, Sobhan Takaloo, Mahdi Rezaei, Seyed Davar Siadat · 2024 · International Journal of Hepatology
27. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and hepatic steatosis and liver fibrosis among US adults based on NHANES
    Baoyu Li, Yuwei Liu, Xiaorong Ma, Xiaoyan Guo · 2025 · Scientific Reports
28. Emerging Roles of Periodontal Pathogen–Derived Outer Membrane Vesicles in NAFLD
    Congcong Lv, Kaikai Shi, Ya-Dong Guo, Zixin Guo, Pingchan Luo, Lijing Wang, Zhe Wu, Pei Lin Yu · 2025 · International Dental Journal
29. The Liver in Diabetes and Metabolic Syndrome
    Mia C. Mahmoud, Manal F. Abdelmalek · 2025 · Clinics in Liver Disease
30. The role of vitamin D3 in modulating the interplay between NLRP3 inflammasome and autophagy in NASH
    Basma A. Abdelrahman, Olfat Ali Hammam, Aiman Saad El-Khatib, Yasmeen M. Attia · 2023 · Biochemical and Biophysical Research Communications
31. Recent advances in understanding/management of non-alcoholic steatohepatitis
    Tommy Pacana, Arun Jayant Sanyal · 2015 · F1000Prime Reports
32. Treatment with Rhodiola crenulata root extract ameliorates insulin resistance in fructose-fed rats by modulating sarcolemmal and intracellular fatty acid translocase/CD36 redistribution in skeletal muscle
    Ting Chen, Ling Yao, Dazhi Ke, Weiguo Cao, Guowei Zuo, Liang Fu Zhou, Jian Wei Jiang, Johji Yamahara, Yuhao Li, Jianwei Wang · 2016 · BMC Complementary and Alternative Medicine
33. Obesity and Nonalcoholic Fatty Liver Disease
    Vanessa Bullón‐Vela, Itziar Abete, José Alfredo Martínez, M. Ángeles Zulet · 2018 · Elsevier eBooks
34. Application of a Novel Mass Spectral Data Acquisition Approach to Lipidomic Analysis of Liver Extracts from Sitaxentan-Treated Liver-Humanized PXB Mice
    Adam M. King, Matthew Baginski, Yoshio Morikawa, Paul D. Rainville, Lee A. Gethings, Ian D. Wilson, Robert S. Plumb · 2019 · Journal of Proteome Research
35. Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
    Eddison Godinez Leiva, Fernando Bril · 2020 · Current Hypertension Reviews
36. Mechanisms of nonalcoholic steatohepatitis-associated cardiomyopathy: key roles for liver–heart crosstalk
    Dolores B. Njoku, Joel D. Schilling, Brian N. Finck · 2022 · Current Opinion in Lipidology
37. Icosabutate: targeting metabolic and inflammatory pathways for the treatment of NASH
    David A. Fraser, Stephen A. Harrison, Detlef Schuppan · 2022 · Expert Opinion on Investigational Drugs
38. Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis
    Irina V. Kholodenko, K. N. Yarygin · 2023 · Biomedicines
39. A scientifically validated combination of garcinol, curcuminoids, and piperine for mild to moderate nonalcoholic steatohepatitis patients—results from a randomized, double-blind, placebo-controlled study
    Muhammed A. Majeed, Kalyanam Nagabhushanam, Mazen Noureddin, Shaji Paulose, Chinmoy Barik, Santosh Saklecha, Lakshmi Mundkur · 2023 · Frontiers in Nutrition
40. DWN12088, A Prolyl-tRNA Synthetase Inhibitor, Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis
    Dong‐Keon Lee, Su Ho Jo, Eun Soo Lee, Kyung Bong Ha, Na Won Park, Deok-Hoon Kong, Sang‐In Park, Joon Seok Park, Choon Hee Chung · 2024 · Diabetes & Metabolism Journal
41. Platelet-derived mitochondria regulate lipid metabolism in nonalcoholic steatohepatitis through extracellular vesicles
    Tsai‐Ling Liao, Der-Yuan Chen, Shie-Liang Hsieh, Yingying Yang, Yi‐Ming Chen, Kuo‐Tung Tang, Chung‐Hsin Chang, Sheng‐Shun Yang · 2024 · Hepatology
42. Obesity-induced chronic low grade inflammation: Gastrointestinal and adipose tissue crosstalk
    Aaron M. Magnuson, Josephine K. Fouts, Andrea D. Booth, Michelle T. Foster · 2015 · Integrative Obesity and Diabetes
43. Longdan Xiegan Tang attenuates liver injury and hepatic insulin resistance by regulating the angiotensin-converting enzyme 2/Ang (1–7)/Mas axis-mediated anti-inflammatory pathway in rats
    Chengliang Wang, Liying Ren, Shankang Chen, Huihui Zheng, Yifan Yang, Tieguang Gu, Yuhao Li, Chunxia Wang · 2021 · Journal of Ethnopharmacology
44. Deficiency of peroxisomal NUDT7 stimulates de novo lipogenesis in hepatocytes
    Jinsoo Song, In‐Jeoung Baek, Sujeong Park, Jinjoo Oh, Deokha Kim, Kyung Song, Mi Kyung Kim, Hye Won Lee, Byoung Kuk Jang, Eun‐Jung Jin · 2022 · iScience
45. ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation
    Danli Kong, Zhenhua Mai, Yongze Chen, Ling Luo, Hao Liu, Zhao Le, Ruixian Huang, Shuang Wang, Rong Chen, Hao Zhou et al. · 2022 · Pharmaceuticals
46. Glitazones for human nonalcoholic steatohepatitis
    Raluca Pais, I Moraru, Vlad Ratziu · 2011 · Therapeutic Advances in Gastroenterology
47. Jiangzhi Capsule improves fructose-induced insulin resistance in rats: Association with repair of the impaired sarcolemmal glucose transporter-4 recycling
    Lirong Jiang, Ling Yao, Yifan Yang, Dazhi Ke, Robert Gordon Batey, Jianwei Wang, Yuhao Li · 2016 · Journal of Ethnopharmacology
48. Distinct Influence of Hypercaloric Diets Predominant with Fat or Fat and Sucrose on Adipose Tissue and Liver Inflammation in Mice
    Caíque Silveira Martins da Fonseca, Joshua E. Basford, David G. Kuhel, Eddy S. Konaniah, James G. Cash, Vera Lúcia de Menezes Lima, David Y. Hui · 2020 · Molecules
49. miR-23b Ameliorates nonalcoholic steatohepatitis by targeting Acyl-CoA thioesterases 4
    Hongzhi Li, Xiang Li, Shanshan Yu, Yanling Hu, Licheng Xu, Tianhe Wang, Xiaohong Yang, Xinyi Sun, Binghai Zhao · 2021 · Experimental Cell Research
50. Translational Control in Liver Disease
    Alexandra Balvey, Mercedes Fernández · 2021 · Frontiers in Physiology
51. In the non-cirrhotic stage of nonalcoholic steatohepatitis, angioarchitecture of portal veins and lobular architecture are maintained
    Hiroshi Hano, Satoshi Takasaki, Hirohiko Kobayashi, Tomoki Koyama, Tomoe Lu, Keisuke Nagatsuma · 2013 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
52. Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?
    Kathleen E. Corey, Naga Chalasani · 2011 · Hepatology
53. Atorvastatin and Flaxseed Effects on Biochemical Indices and Hepatic fat of NAFLD Model in Rats
    Zahra Eslami, Abdorreza Eghbal Moghanlou, Yahya Mohammadnejadpanah Kandi, Mehdi Sheikh Arabi, Alireza Norouzi, Hamidreza Joshaghani · 2023 · Advanced Biomedical Research
54. Nicotine aggravates high-fat diet-induced non-alcoholic fatty liver disease in mice via inhibition of CISD3
    Yi-Feng Wei, Tongtong Pan, Youhong Zhao, Zhiyi Chen, Lina Wu, Xiaowei Wang, Xiaodong Wang, Xiaodong Wang, Dazhi Chen, Yongping Chen · 2024 · International Immunopharmacology
55. Natural linoleic acid from marine fungus Eutypella sp. F0219 blocks KEAP1/NRF2 interaction and ameliorates MASLD by targeting FABP4
    Chenyan Wu, Yue Chen, Mengting Chen, Tingting Fu, Jin Liu, Fei‐Fei Liu, Congjun Xu, Wan-shan Li, Bao-Li Li, Zhong-ping Jiang et al. · 2024 · Free Radical Biology and Medicine
56. Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex
    Elena Gangitano, Francesca Scannapieco, Carla Lubrano, Lucio Gnessi · 2024 · Livers
57. Zhuyu pill attenuates metabolic-associated fatty liver disease by regulating macrophage polarization through TLR4 signaling pathway
    Mei Zhao, Qingman He, Xinyao Shu, Ruitong Xu, Zhongyi Zhang, Yu Mou, Wenhao Liao, Yong Zhang, Zubing Zhou, Tao Shen · 2025 · Phytomedicine
58. Mechanisms underpinning the effect of exercise on the non-alcoholic fatty liver disease: review
    Mohamed Bekheit, B S Kamera, Laura Colacino, Anne Dropmann, Mirela Delibegović, Fatema Almadhoob, Nemany A. N. Hanafy, Giovanna Bermano, Seddik Hammad · 2024 · EXCLI journal
59. Glycogen Synthase Kinase 3 β Hepatocyte Deletion Attenuates Ferroptosis and Metabolic Dysfunction-associated Steatohepatitis in Mice
    Khaled Warasnhe, Akitoshi Sano, Qianqian Guo, Nantawat Satthawiwat, Xin Dai, Peyton Classon, Chady Meroueh, Hyun Se Kim Lee, Lucía Valenzuela-Pérez, Stella G. Victorelli et al. · 2025 · Cellular and Molecular Gastroenterology and Hepatology
60. An oral, liver-restricted LXR inverse agonist for dyslipidemia: preclinical development and phase 1 trial
    Xiaoxu Li, Giorgia Benegiamo, Archana Vijayakumar, NATALIE SRODA, Masaki Kimura, Ryan S. Huss, STEVE WENG, Eisuke Murakami, Brian J. Kirby, Giacomo von Alvensleben et al. · 2026 · Nature Medicine
61. Hígado graso no alcohólico. Documento de posicionamiento de la Societat Catalana de Digestologia
    Llorenç Caballería, Joan Saló, Annalisa Berzigotti, Ramón Planas, Maria Carme Vila, Carlos Huertas, Miquel Torres, Pere Torán‐Monserrat, Joan Caballería · 2014 · Gastroenterología y Hepatología
62. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms
    Søren Møller, Nina Kimer, Thit Mynster Kronborg, Josephine Grandt, Jens Dahlgaard Hove, Mads Christian Johannes Barloese, Lise Lotte Gluud · 2021 · Seminars in Liver Disease
63. The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Yuxian Yang, Shuting Li, Yuechao Xu, Jing Ke, Dong Zhao · 2022 · Diabetes Metabolic Syndrome and Obesity
64. Mechanism insights into the pleiotropic effects of nobiletin as a potential therapeutic agent on non-alcoholic fatty liver disease (NAFLD)
    Qiqi Ran, Qianrong Gan, Ye Zhu, Song Li, Longyu Shen, Xinyi Duan, Xinyun Zhu, Wei Huang · 2024 · Biomedicine & Pharmacotherapy
65. The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease
    Moon Young Kim · 2017 · Korean Journal of Gastroenterology
66. Novel substituted pyrazolone derivatives as AMP-activated protein kinase activators to inhibit lipid synthesis and reduce lipid accumulation in ob/ob mice
    Mei Zhang, Zhifu Xie, Runtao Zhang, Da-Kai Chen, Min Gu, Shichao Cui, Yangming Zhang, Xinwen Zhang, Yanyan Yu, Jia Xuan Li et al. · 2018 · Acta Pharmacologica Sinica
67. Lack of Augmenter of Liver Regeneration Disrupts Cholesterol Homeostasis of Liver in Mice by Inhibiting the AMPK Pathway
    Xin Wang, Ling‐yue Dong, Qu‐Jing Gai, Weilun Ai, Yuan Shan Wu, Weichun Xiao, Jing Zhang, Wei An · 2020 · Hepatology Communications
68. A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet
    Noriko Suzuki‐Kemuriyama, Akari Abe, Kinuko Uno, Shuji Ogawa, Atsushi Watanabe, Ryuhei Sano, Megumi Yuki, Katsuhiro Miyajima, Dai Nakae · 2020 · Lipids in Health and Disease
69. Apolipoprotein A5 gene polymorphisms are associated with non-alcoholic fatty liver disease
    Yue Xu, Linlin Lu, Shousheng Liu, Shui-Xian Du, Huiling Zhu, Quanjiang Dong, Yongning Xin · 2018 · Hepatobiliary & pancreatic diseases international
70. Glabridin ameliorates intracellular events caused by palmitic acid and alcohol in mouse hepatocytes and fast food diet and alcohol -induced steatohepatitis and fibrosis in C57BL/6J mice model
    Raghu Rai Sharma, Haroon Rashid, Aalim Maqsood Bhat, Sajeeda Archoo, Ragni Gupta, Sheikh Tasduq Abdullah · 2023 · Food and Chemical Toxicology
71. Association between the NHHR and hepatic steatosis and liver fibrosis: a population-based study
    Xiaoxian Yang, Haiyi Yan, Rui Guo, Yan Chen · 2025 · Scientific Reports
72. Disrupted minor intron splicing activates reductive carboxylation-mediated lipogenesis to drive metabolic dysfunction–associated steatotic liver disease progression
    Yinkun Fu, Xin Peng, Hongyong Song, Xiaoyun Li, Yang Zhi, Jie Ting Tang, Yifan Liu, Ding Chen, Wenyan Li, Jing Zhang et al. · 2025 · Journal of Clinical Investigation
73. Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and mortality in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): data from the NHANES III (1988–1994)
    Ying Zhang, Pengyu Luo, Yu-Na Tang, Jing Wang, Shuai Gao, Yu‐Chen Fan, Kai Wang · 2025 · Nutrition & Metabolism
74. The gut–adipose/pancreas axis: a novel perspective on glycolipid metabolism dysregulation in MAFLD and T2DM pathogenesis
    Jiahui Liang, Xingyu Chen, Yunhang Chu, Yan Leng · 2025 · Frontiers in Endocrinology
75. Relevance of lipid droplets in metabolic dysfunction-associated steatotic liver disease
    Ralf Weiskirchen, Amedeo Lonardo · 2026 · Expert Opinion on Therapeutic Targets
76. Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence
    Leonardo Gomes da Fonseca, Pedro Henrique Shimiti Hashizume, Irai Santana de Oliveira, Laura Izquierdo‐Sánchez, Lisa Rodrigues da Cunha Saud, Mariana Pinheiro Xerfan, Venâncio Avancini Ferreira Alves, Evandro Sobroza de Mello, Paulo Herman, Jesús M. Bañales et al. · 2022 · Cancers
77. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease
    Tan Dao-yu, Haiyan Shi, Changping Li, Xiao-Ling Zhong, Ming Kang · 2015 · World Journal of Gastroenterology
78. The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice with nonalcoholic fatty liver disease
    Bojan Z. Jorgačević, Danijela B. Vučević, Ivana D. Djuricic, Sladjana S. Sobajic, Dušan R. Mladenović, Milena N. Vesković, Rada Ješić-Vukićević, Tatjana S. Radosavljević · 2017 · Chemistry and Physics of Lipids
79. Basic science to clinical trials in non-alcoholic fatty liver disease and alcohol-related liver disease: collaboration with industry
    Amon Asgharpour, Amreen M. Dinani, Scott L. Friedman · 2020 · Translational Gastroenterology and Hepatology
80. Bridelia ferruginea Benth. (Euphorbiaceae) mitigates oxidative imbalance and lipotoxicity, with concomitant modulation of insulin signaling pathways via GLUT4 upregulation in hepatic tissues of diabetic rats
    Olajumoke Arinola Oyebode, Ochuko Lucky Erukainure, Anil Amichund Chuturgoon, Terisha Ghazi, Pragalathan Naidoo, Chika Ifeanyi Chukwuma, Md. Shahidul Islam · 2021 · Journal of Ethnopharmacology
81. Qualitative and Quantitative Changes in Total Lipid Concentration and Lipid Fractions in Liver Tissue of Periparturient German Holstein Dairy Cows of Two Age Groups
    Kirsten B. Theinert, Teja Snedec, Fabian Pietsch, Sabrina Theile, Anne-Sophie Leonhardt, Joachim Spilke, Stefan Pichelmann, Erik Bannert, Kristin Reichelt, Gabriele Dobeleit et al. · 2022 · Frontiers in Veterinary Science
82. Effect of Aerobic Exercise on Lipid Metabolism in Rats With NAFLD
    Tongxi Zhou, Mengfan Niu, Ruichen Liu, Li Li · 2022 · Frontiers in Genetics
83. Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD
    Lucia Carulli, Mauro Maurantonio, Lionel Hebbard, Enrica Baldelli, Paola Loria, Jacob George · 2012 · Current Pharmaceutical Design
84. Definition, Pathogenesis, and Natural Progress of Non-alcoholic Fatty Liver Disease
    Jae‐Han Jeon, Keun‐Gyu Park · 2014 · Journal of Korean Diabetes
85. Prevalence and Predictor of Nonalcoholic Steatohepatitis (NASH) in Nonalcoholic Fatty Liver Disease (NAFLD)
    Shahinul Alam, Mahabubul Alam, Sheikh Mohammad Noor E Alam, Ziaur Rahman Chowdhury, Jahangir Kabir · 2015 · Journal of Bangladesh College of Physicians and Surgeons
86. Senna alata leaf extract restores insulin sensitivity in high-fat diet-induced obese mice
    Jarinyaporn Naowaboot, Pritsana Piyabhan · 2016 · Clinical Phytoscience
87. A mixture of apple pomace and rosemary extract improves fructose consumption-induced insulin resistance in rats: modulation of sarcolemmal CD36 and glucose transporter-4.
    Peng Ma, Ling Yao, Xuemei Lin, Tieguang Gu, Xianglu Rong, Robert Gordon Batey, Johji Yamahara, Jianwei Wang, Yuhao Li · 2016 · PubMed Central
88. Evaluating the Influence of Side Stream Cigarette Smoke at an Early Stage of Non-Alcoholic Steatohepatitis Progression in Mice
    Jong Won Kim, Hyejin Yun, Seong‐Jin Choi, Sang Hyub Lee, Surim Park, Chae Woong Lim, Kyuhong Lee, Bumseok Kim · 2017 · Toxicological Research
89. Nonalcoholic fatty liver disease can be predicted by retinal vascular changes in patients with obesity without hypertension or diabetes
    María Elena Romero-Ibarguengoitia, Arturo Herrera-Rosas, Alfredo A. Domínguez-Mota, Jinny T. Camas-Benitez, María Fabiola Serratos-Canales, Mireya León-Hernández, Antonio González-Chávez, Eduardo López‐Ortiz, Srinivas Mummidi, Ranvidranth Duggirala et al. · 2017 · European Journal of Gastroenterology & Hepatology
90. Programming of hepatic lipid metabolism in a rat model of postnatal nicotine exposure – Sex-related differences
    Iala Milene Bertasso, Carla Bruna Pietrobon, Bruna Pereira Lopes, Thamara Cherem Peixoto, P.N. Soares, ELAINE BEZERRA DE OLIVEIRA, Alex C. Manhães, Maria Lúcia Bonfleur, Sandra Lucinei Balbo, Suellen Silva Cabral et al. · 2019 · Environmental Pollution
91. Fatty Liver Disease
    DINA G. TINIAKOS, Quentin Mark Anstee, Elizabeth M. Brunt, Alastair D. Burt · 2023 · Elsevier eBooks
92. Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease
    Yutian Zhang, Tianlin Wang, Junquan Han, Jielin Song, Chaoshuai Yang, Lei Liang, Huizhen Li, Hong Wang · 2025 · Frontiers in Pharmacology
93. The inflammatory index and cytokines are associated with non-alcoholic fatty liver disease in type 2 diabetes mellitus
    Ruiqing Liu, Ruiyan Liu, Mingjuan Liu, Yaqiong Tian, Jie Liu, Yao Wang, Qiangjun Sui, Jiandong Zhang, Hongmin Xu, Zhi Qi · 2025 · Frontiers in Medicine
94. The heterogeneity of monocyte-derived macrophages in MASH pathogenesis
    Miao Zhang, Erzhuo Xia, Chongxiao Li, Shuoyi Ma, Fangfang Yang, Siyuan Tian, Xia Zhou, Xiaohong Zheng, Bo Li, Hui Jun Yang et al. · 2025 · Cell Communication and Signaling
95. Nutritional Composition and Effect of Loquat Fruit (Eriobotrya japonica L. var. Navela) on Lipid Metabolism and Liver Steatosis in High-Fat High-Sucrose Diet-Fed Mice
    Imane Mokhtari, Mohammadine Moumou, Chakib Mokhtari, Mohamed Harnafi, Dragan Milenković, Souliman Amrani, Hicham Harnafi · 2024 · Preventive Nutrition and Food Science
96. Exogenous Mitochondrial Pretreatment Enhances the Therapeutic Effect of UC‐MSCs on NAFLD in Type 2 Diabetic Mice by Mediating Mitochondrial Transfer
    Hu, Ruofan, Zhao, Jian, Cheng, Yu, Su, Wanlu, Ren, Rui, Zhang, Haixia, Zhang, Yue, Wang, Anning, Mu, Yiming, Yu, Songyan · 2025 · Stem Cells International
97. Accurate quantification of hepatic fat—is it important?
    Leon Anton Adams · 2015 · Nature Reviews Gastroenterology & Hepatology
98. 1,25-Dihydroxycholecalciferol down-regulates 3-mercaptopyruvate sulfur transferase and caspase-3 in rat model of non-alcoholic fatty liver disease
    Maher Ibrahim, Abeer A. Khalefa, Dalia A. Hemead, Amira Ebrahim Alsemeh, Marwa A Habib · 2023 · Journal of Molecular Histology
99. Cholesterol dynamics in rabbit liver: High-fat diet, olive oil, and synergistic dietary effects
    Abi Karenina Funes, Virginia Avena, Paola Vanina Boarelli, Maria Angeles Monclus, Darío Fernández, Tania E. Sáez Lancellotti, Miguel W. Fornés · 2024 · Biochemical and Biophysical Research Communications
100. Consequences of PPARαInvalidation on Glutathione Synthesis: Interactions with Dietary Fatty Acids
     Najoua Guelzim, Jean‐François Huneau, Véronique Mathé, Annie Quignard‐Boulangé, Pascal G.P. Martin, Daniel Tomé, Dominique Hermier · 2011 · PPAR Research